Ertapenem Sodium Injection, Powder, Lyophilized, For Solution
Product Images NDC 0143-9398

2 FDA label images from Hikma Pharmaceuticals Usa, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ertapenem Sodium (NDC 0143-9398). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Structural Formula (Image 01)

Structural Formula (Image 01)
Chemical structure of ertapenem sodium, showing the molecular arrangement including rings, functional groups, and the sodium salt form as part of the structure.*
FDA Label Image

Hikma Ertapenem 1 Gram Vial Label (Image 02)

Hikma Ertapenem 1 Gram Vial Label (Image 02)
Label for ertapenem sodium injection, powder, lyophilized for solution, containing 1 g per vial. Intended for intravenous or intramuscular use, single-dose vial. The label includes usage instructions, inactive ingredients, storage conditions, distributor information (Hikma Pharmaceuticals USA, Inc., Berkeley Heights, NJ), and indicates the product is made in Italy. NDC 0143-9398.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.